Carlisle Companies Incorporated (CSL) News
Follow Carlisle Companies Incorporated (CSL) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 41 public stories across 27 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Carlisle Companies to Acquire Georgia-Based Permatherm
EQUITY | Nov 17, 2026, 03:04 PM UTC
M
Carlisle Companies to Acquire PermaTherm
Carlisle Companies said it will acquire PermaTherm, a Georgia-based manufacturer of insulated metal panels.
EQUITY | Nov 17, 2026, 02:15 PM UTC
M
Carlisle Reports Third-Quarter 2026 Revenue of $1.46B, EPS of $5.24
Revenue rose 8.6% year over year to $1.46B; net income fell 2.8% to $208.1M, while diluted EPS increased 5.2% to $5.24. The company cited higher volumes, pricing and freight surcharges for revenue growth.
EQUITY | Oct 29, 2026, 08:02 PM UTC
M
Carlisle Companies Reports Third-Quarter Profit of $208.1 Million
Carlisle reported third-quarter profit of $208.1 million, or $5.24 per share, compared with $214.2 million, or $4.98 per share, a year earlier. The supplied body is truncated before adjusted results.
EQUITY | Oct 28, 2026, 09:34 PM UTC
M
Carlisle Companies Reports Third-Quarter Results
EQUITY | Oct 28, 2026, 08:35 PM UTC
M
Carlisle Companies Q3 Revenue Beats Estimates on CCM Growth
Carlisle Companies said Q3 revenue rose and beat estimates, citing growth in CCM.
EQUITY | Oct 28, 2026, 08:30 PM UTC
M
Carlisle Companies Reports Q3 Adjusted EPS of $5.92
Carlisle Companies reported Q3 adjusted EPS of $5.92, versus a FactSet estimate of $5.89.
EARNINGS | Oct 28, 2026, 08:13 PM UTC
M
CSL Q3'26 Earnings Preview
CSL is scheduled to report Q3'26 results October 28 after the market closes.
EQUITY | Oct 27, 2026, 11:02 AM UTC
M
CSL FY26 Underlying NPAT Falls 3% to $2.8 Billion
CSL reported FY26 underlying net profit after tax of $2.8 billion, down 3% year over year. Reported net loss after tax was $2.6 billion. The company reaffirmed its FY27 outlook.
EARNINGS | Oct 27, 2026, 06:18 AM UTC
M
CSL Q3'26 Earnings Preview
CSL is expected to report Q3'26 results on October 22. Revenue and EPS estimates were provided; the release time is not specified.
EQUITY | Oct 15, 2026, 11:01 AM UTC
M
Carlisle Companies to report third-quarter 2026 results October 28
EQUITY | Oct 14, 2026, 08:06 PM UTC
M
Australian shares edge higher as CSL deal lifts healthcare stocks
Australian shares closed slightly higher on Monday, with a rally in biopharmaceutical giant CSL boosting healthcare stocks in thin holiday trade. The benchmark S&P/ASX 200 index closed 0.1% higher at 8,686.40 points.
EQUITY | Oct 05, 2026, 06:32 AM UTC
M
CSL inks $1.6B rare disease drug deal with Alentis Therapeutics
CSL has entered into an agreement with Alentis Therapeutics to co-develop and co-promote a treatment for rare kidney and liver diseases, in a deal potentially worth up to $1.6 billion before development funding.
EQUITY | Oct 04, 2026, 10:09 PM UTC
H
CSL Still Generates Caution Despite Rerate — Market Talk
CSL still generates caution at Macquarie despite the stock's recent rerate. Analysts at the investment bank keep a neutral rating on the Australia-based pharmaceutical company, observing that a 58% share-price rise over
EARNINGS | Sep 30, 2026, 04:52 AM UTC
L
CSL Target Price Raised 31% to A$174.00/Share by Macquarie>CSL.AU
CSL Target Price Raised 31% to A$174.00/Share by Macquarie>CSL.AU
NEWS | Sep 29, 2026, 11:44 PM UTC
L
CSL Seqirus Expands U.S. Availability Of Influenza Vaccine
CSL Seqirus
NEWS | Sep 29, 2026, 03:32 PM UTC
L
CSL Seqirus Expands U.S. Influenza Vaccine Availability Ahead Of Flu Season
CANBERA (dpa-AFX) - Tuesday, CSL Seqirus, a business of CSL (CSL.AX), said it has expanded the availability of influenza vaccines in the U.S. following the successful completion of its 2026/27 manufacturing campaign.The
NEWS | Sep 29, 2026, 02:08 PM UTC
L
CSL Seqirus Expands U.S. Availability of Influenza Vaccine following Successful Completion of the 2026/27 Manufacturing Campaign
HOLLY SPRINGS, N.C., Sept. 29, 2026 // -- CSL Seqirus, a business of CSL (ASX:CSL), today announced expanded availability of influenza vaccine in the United States following the successful completion of its 2026/27 manuf
NEWS | Sep 29, 2026, 01:31 PM UTC
L
CSL Ltd And AWS Collaborate To Advance Biopharmaceutical Research And Development
CSL Limited ASX:CSL
NEWS | Sep 29, 2026, 01:49 AM UTC
L
Australia's CSL taps Amazon's cloud unit to boost research pipeline
Australian biotechnology firm CSL ASX:CSL said on Tuesday it is collaborating with Amazon's NASDAQ:AMZN cloud arm to harness AI and cloud technology across its research and clinical development pipeline.Here are some mor
NEWS | Sep 29, 2026, 12:41 AM UTC
M
CSL Seqirus partnership expanded; UK to introduce AUJEMFLU (aTIVc)
CSL Seqirus says it has strengthened its partnership with the UK Government, with the UK set to be the first country to introduce AUJEMFLU (adjuvanted cell-based) flu vaccine (aTIVc) and an extended health security pande
EQUITY | Sep 21, 2026, 11:01 PM UTC
L
Australian shares inch higher as healthcare and staples gain
Australian shares inched higher on Monday, buoyed by domestic staples stocks and healthcare firms, though losses in miners capped the advance as renewed Middle East hostilities lifted oil prices and curbed risk appetite.
COMMODITIES | Sep 14, 2026, 01:33 AM UTC
L
Jesse G. Singh resigns from Carlisle board after employment change
Carlisle Companies said director Jesse G. Singh resigned from the board effective at the conclusion of the board meeting on September 10, 2026. The item cites an 8-K filing.
EQUITY | Sep 10, 2026, 08:13 PM UTC
L
CSL drove ASX healthcare’s stellar reporting season, but what’s next?
Healthcare has been the ASX's problem child for the best part of this decade, leaving the market's most defensive sector as one of its worst performers. Between 2020 and 2025, the ASX 200 Healthcare Sector Index (XHJ) re
EQUITY | Sep 07, 2026, 01:46 AM UTC
M
Citi: CSL Injectafer black box label warning likely limited impact
Citi says the FDA-approved revised Injectafer labeling—adding a black box warning about low blood phosphate risk—is unlikely to change much for CSL.
EQUITY | Sep 02, 2026, 11:34 PM UTC
L
Continental Securities appoints Rajesh Khuteta as chairman
Continental Securities Ltd appointed Rajesh Khuteta as managing director and chairman.
EQUITY | Sep 02, 2026, 07:32 AM UTC
L
CSL investors see limited direct impact from U.S. pricing deals
UBS analysts cited by market talk say CSL’s U.S. pricing agreements—giving Medicaid access at comparable prices—are unlikely to have much direct financial impact.
EQUITY | Sep 02, 2026, 02:29 AM UTC
L
CSL's U.S. Agreements Remove Two Stock Overhangs — Market Talk
CSL's U.S. Agreements Remove Two Stock Overhangs — Market Talk
EQUITY | Sep 01, 2026, 02:22 AM UTC
L
Trump administration to announce drug pricing deals
TradingView News reports the Trump administration will announce drug pricing deals.
EQUITY | Aug 31, 2026, 04:07 PM UTC
L
How high can BHP go? Plus: uranium, lithium and copper commodity charts and ASX sector reviews
How high can BHP go? Plus: uranium, lithium and copper commodity charts and ASX sector reviews
COMMODITIES | Aug 26, 2026, 11:37 PM UTC
M
Australia stocks rise as miners and healthcare rally
Australian shares rose 31 points, or 0.4%, to 9,085 in Thursday morning trade, snapping a six-session losing streak as miners and healthcare led gains while major banks fell.
EQUITY | Aug 20, 2026, 02:03 AM UTC
H
ASX 200 slips for sixth straight session to two-week low
Australian equities fall 0.3% to 9,042 in early trade for a sixth session, hitting a two-week low, as U.S. stock futures, bond rout dynamics, and higher oil prices weigh on sentiment.
MACRO | Aug 19, 2026, 12:58 AM UTC
L
CSL Publishes Sustainability Report
CSL releases corporate sustainability report
EQUITY | Jul 31, 2026, 01:34 PM UTC
L
CSL - Carlisle Companies Reports Second Quarter Results
CSL - Carlisle Companies Reports Second Quarter Results
EARNINGS | Jul 29, 2026, 08:13 PM UTC
L
CSL Carlisle Companies RESULTS: Q2, Q2 Net Income $255.2M, Q2 REV $1,570.3M vs. EST $1.476B, Q2 EPS $6.36
CSL Carlisle Companies RESULTS: Q2, Q2 Net Income $255.2M, Q2 REV $1,570.3M vs. EST $1.476B, Q2 EPS $6.36
EARNINGS | Jul 29, 2026, 08:09 PM UTC
L
Near 200dma support DUK WMS EXC TMO GXO ATO HOOD DCI TJX META MAA XEL RCL COF CSL AGCO ZBH CMS CDNS EMN MSA BILL
Near 200dma support DUK WMS EXC TMO GXO ATO HOOD DCI TJX META MAA XEL RCL COF CSL AGCO ZBH CMS CDNS EMN MSA BILL
EQUITY | Jul 17, 2026, 04:41 PM UTC
L
CSL IBP TREX AWI Higher-for-longer rates continue to pressure housing-related demand @ GSCO
CSL IBP TREX AWI Higher-for-longer rates continue to pressure housing-related demand @ GSCO
EQUITY | Jul 14, 2026, 12:58 PM UTC
L
Why Owens Corning Stock Rocked the Market This Week
2026-07-03 20:38:36 ET Owens Corning (NYSE: OC), a storied company though rarely an investor dar
EQUITY | Jul 04, 2026, 12:43 AM UTC
L
The BHP (ASX:BHP) share price soared more than 60% in FY26
2026-07-02 23:30:59 ET The BHP Group Ltd (ASX:BHP) share price was one of the best performers in the S&P/ASX 200 Index (ASX: XJO) in the 2026 financial year. The p
RATES | Jul 03, 2026, 03:43 AM UTC
L
Reportedly Carlisle Companies make unsolicited offer of nearly $11B; Owens Corning has not 'engaged substantially' about deal - WSJ
Link
EQUITY | Jun 29, 2026, 06:35 PM UTC
M
Construction-Products Supplier Carlisle Made Unsolicited Offers For Rival – WSJ
READ HERE
EQUITY | Jun 29, 2026, 05:09 PM UTC